At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,635 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Long Term Documentation to Demonstrate Long Term Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis Under Conditions of Daily Practice
In Brief
An observational study for Psoriatic Arthritis. Completed, enrolled 4,635 participants across 509 sites.
Detailed Summary
This study is a documentation of effectiveness and safety of Humira in patients with psoriatic arthritis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriatic Arthritis
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2005
First PostedApr 2010
Primary CompletionDec 2013
TodayJul 2026
First PostedApr 27, 2010
Enrollment StartAug 1, 2005
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 16.2 years ago